期刊文献+

CXCL2在结直肠癌中的表达及临床意义 被引量:3

Expression and clinical significance of CXCL2in colorectal cancer
下载PDF
导出
摘要 目的检测CXCL2蛋白在结直肠癌中的表达情况,探讨其临床研究意义。方法利用Oncomine芯片数据库分析6个独立的研究中结直肠癌CXCL2mRNA的表达数据。采用组织芯片(TMA)免疫组化染色检测结直肠癌CXCL2蛋白的表达情况,并用统计学分析其与临床病理特征和预后的相关性。结果 CXCL2在结直肠癌较其癌旁组织中高表达;31.31%的结直肠癌细胞质CXCL2高表达,与肿瘤部位(P=0.022)、原发肿瘤的浸润程度(P=0.005)及淋巴结转移(P=0.017)显著相关;Kaplan-Meier和Cox回归分析表明,CXCL2高表达(P<0.001)是结直肠癌预后不良的一项独立预测因素。结论 CXCL2高表达可能与结直肠癌的侵袭和转移有关,可作为结直肠癌的预后指标和治疗的潜在靶点。 Objective To detect the expression condition of chemokine(C-X-C motif)ligand 2(CXCL2)in colorectal cancer(CRC)and to study its significance in clinical research.Methods The data of colorectal cancer CXCL2 mRNA expression in 6independent research centers were analysed by using the Oncomine microarray database.The tissue microarray(TMA)immunohistochemistry staining was employed to characterize the expression of the CXCL2 protein in CRC.The correlation of CXCL2 expression with clinicopathological features and prognosis was analyzed by statistics.Results CXCL2 was highly expressed in CRC tissues compared with corresponding peritumoral tissues.31.31% of CXCL2 cytoplasm in CRC was highly expressed,which was significantly correlated with the tumor location(P=0.022),infiltration extent of primary tumor(P=0.005)and lymph node metastasis(P=0.017).The Kaplan-Meier and Cox regression analysis revealed that high CXCL2 expression was an independent predictive factor of poor prognosis in CRC.Conclusion High CXCL2 expression may be associated with invasion and metastasis of CRC,which can be used as a prognostic index and potential target for the treatment of CRC.
出处 《检验医学与临床》 CAS 2016年第8期1045-1048,共4页 Laboratory Medicine and Clinic
关键词 CXCL2 结直肠癌 组织芯片 免疫组化 预后 CXCL2 colorectal cancer tissue microarray immunohistochemistry prognosis
  • 相关文献

参考文献2

二级参考文献47

  • 1Li ~, Flores R, Yu A, Okcu MF, Murray J, Chintagumpala M, Hicks J, Lau CC, Man TK. Elevated expression of CXC che- mokines in pediatric osteosarcoma patients. Cancer 2011; 117: 207-217.
  • 2Deng L, Chen N, Li Y, Zheng H, Lei Q. CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer. Biochim Biophys Acta 2010; 1806:42-49.
  • 3Modi WS, Yoshimura T. Isolation of novel GRO genes and a phylogenetic analysis of the CXC chemokine subfamily in mammals. Mol BioI Evol 1999; 16:180-193.
  • 4Wang D, Yang W, Du J, Devalaraja MN, Liang P, Matsumo- to K, Tsubakimoto K, Endo T, Richmond A. MGSA/GRO- mediated metanocyte transformation involves induction of Ras expression. Oncogene 2000; 19:4647-4659.
  • 5Wang JM, Deng X, Gong W, Su S. Chemokines and their role in tumor growth and metastasis. J Immunol Methods 1998; 220:1-17.
  • 6Belperio JA, Keane MP, Arenberg DA, Addison CL, Ehlert JE, Burdick MD, Strieter RM. CXC chemokines in angiogen- esis. J Leukoc Biol 2000; 68:1-8.
  • 7Cyster JG. Chemokines and cell migration in secondary lymphoid organs. Science 1999; 286:2098-2102.
  • 8Wang B, Hendricks DT, Wamunyokoli F, Parker MI. A growth-related oncogene/CXC chemokine receptor 2 auto- crine loop contributes to cellular proliferation in esophageal cancer. Cancer Res 2006; 66" 3071-3077.
  • 9Sun Y, Mi W, Cai J, Ying W, Liu F, Lu H, Qiao Y, Jia W, Bi X, Lu N, Liu S, Qian X, Zhao X. Quantitative proteomic sig- nature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carci- noma. J Proteome Res 2008; 7:3847-3859.
  • 10Kawaguchi H, Ohno S, Miyazaki M, Hashimoto K, Egashira A, Saeki H, Watanabe M, Sugimachi K. CYFRA 21-1 deter- mination in patients with esophageal squamous cell car- cinoma: clinical utility for detection of recurrences. Cancer 2000; 89:1413-1417.

共引文献9

同被引文献18

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部